Global Natural Killer (NK) Cell Therapeutics Market Size, Status and Forecast 2020-2026

1 Report Overview

• 1.1 Study Scope
• 1.2 Key Market Segments
• 1.3 Players Covered: Ranking by Natural Killer (NK) Cell Therapeutics Revenue
• 1.4 Market by Type
  • 1.4.1 Global Natural Killer (NK) Cell Therapeutics Market Size Growth Rate by Type: 2020 VS 2026
  • 1.4.2 Mogamulizumab
  • 1.4.3 Lorvotuzumab Mertansine
  • 1.4.4 Others
• 1.5 Market by Application
  • 1.5.1 Global Natural Killer (NK) Cell Therapeutics Market Share by Application: 2020 VS 2026
  • 1.5.2 Cancer
  • 1.5.3 Cardiovascular Diseases
  • 1.5.4 Others
• 1.6 Study Objectives
• 1.7 Years Considered

2 Global Growth Trends

• 2.1 Global Natural Killer (NK) Cell Therapeutics Market Perspective (2015-2026)
• 2.2 Global Natural Killer (NK) Cell Therapeutics Growth Trends by Regions
  • 2.2.1 Natural Killer (NK) Cell Therapeutics Market Size by Regions: 2015 VS 2020 VS 2026
  • 2.2.2 Natural Killer (NK) Cell Therapeutics Historic Market Share by Regions (2015-2020)
  • 2.2.3 Natural Killer (NK) Cell Therapeutics Forecasted Market Size by Regions (2021-2026)
• 2.3 Industry Trends and Growth Strategy
  • 2.3.1 Market Top Trends
  • 2.3.2 Market Drivers
  • 2.3.3 Market Challenges
  • 2.3.4 Porter’s Five Forces Analysis
  • 2.3.5 Natural Killer (NK) Cell Therapeutics Market Growth Strategy
  • 2.3.6 Primary Interviews with Key Natural Killer (NK) Cell Therapeutics Players (Opinion Leaders)

3 Competition Landscape by Key Players

• 3.1 Global Top Natural Killer (NK) Cell Therapeutics Players by Market Size
  • 3.1.1 Global Top Natural Killer (NK) Cell Therapeutics Players by Revenue (2015-2020)
  • 3.1.2 Global Natural Killer (NK) Cell Therapeutics Revenue Market Share by Players (2015-2020)
  • 3.1.3 Global Natural Killer (NK) Cell Therapeutics Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
• 3.2 Global Natural Killer (NK) Cell Therapeutics Market Concentration Ratio
  • 3.2.1 Global Natural Killer (NK) Cell Therapeutics Market Concentration Ratio (CR5 and HHI)
  • 3.2.2 Global Top 10 and Top 5 Companies by Natural Killer (NK) Cell Therapeutics Revenue in 2019
• 3.3 Natural Killer (NK) Cell Therapeutics Key Players Head office and Area Served
• 3.4 Key Players Natural Killer (NK) Cell Therapeutics Product Solution and Service
• 3.5 Date of Enter into Natural Killer (NK) Cell Therapeutics Market
• 3.6 Mergers & Acquisitions, Expansion Plans

4 Market Size by Type (2015-2026)

• 4.1 Global Natural Killer (NK) Cell Therapeutics Historic Market Size by Type (2015-2020)
• 4.2 Global Natural Killer (NK) Cell Therapeutics Forecasted Market Size by Type (2021-2026)

5 Market Size by Application (2015-2026)

• 5.1 Global Natural Killer (NK) Cell Therapeutics Market Size by Application (2015-2020)
• 5.2 Global Natural Killer (NK) Cell Therapeutics Forecasted Market Size by Application (2021-2026)

6 North America

• 6.1 North America Natural Killer (NK) Cell Therapeutics Market Size (2015-2020)
• 6.2 Natural Killer (NK) Cell Therapeutics Key Players in North America (2019-2020)
• 6.3 North America Natural Killer (NK) Cell Therapeutics Market Size by Type (2015-2020)
• 6.4 North America Natural Killer (NK) Cell Therapeutics Market Size by Application (2015-2020)

7 Europe

• 7.1 Europe Natural Killer (NK) Cell Therapeutics Market Size (2015-2020)
• 7.2 Natural Killer (NK) Cell Therapeutics Key Players in Europe (2019-2020)
• 7.3 Europe Natural Killer (NK) Cell Therapeutics Market Size by Type (2015-2020)
• 7.4 Europe Natural Killer (NK) Cell Therapeutics Market Size by Application (2015-2020)

8 China

• 8.1 China Natural Killer (NK) Cell Therapeutics Market Size (2015-2020)
• 8.2 Natural Killer (NK) Cell Therapeutics Key Players in China (2019-2020)
• 8.3 China Natural Killer (NK) Cell Therapeutics Market Size by Type (2015-2020)
• 8.4 China Natural Killer (NK) Cell Therapeutics Market Size by Application (2015-2020)

9 Japan

• 9.1 Japan Natural Killer (NK) Cell Therapeutics Market Size (2015-2020)
• 9.2 Natural Killer (NK) Cell Therapeutics Key Players in Japan (2019-2020)
• 9.3 Japan Natural Killer (NK) Cell Therapeutics Market Size by Type (2015-2020)
• 9.4 Japan Natural Killer (NK) Cell Therapeutics Market Size by Application (2015-2020)

10 Southeast Asia

• 10.1 Southeast Asia Natural Killer (NK) Cell Therapeutics Market Size (2015-2020)
• 10.2 Natural Killer (NK) Cell Therapeutics Key Players in Southeast Asia (2019-2020)
• 10.3 Southeast Asia Natural Killer (NK) Cell Therapeutics Market Size by Type (2015-2020)
• 10.4 Southeast Asia Natural Killer (NK) Cell Therapeutics Market Size by Application (2015-2020)

11 India

• 11.1 India Natural Killer (NK) Cell Therapeutics Market Size (2015-2020)
• 11.2 Natural Killer (NK) Cell Therapeutics Key Players in India (2019-2020)
• 11.3 India Natural Killer (NK) Cell Therapeutics Market Size by Type (2015-2020)
• 11.4 India Natural Killer (NK) Cell Therapeutics Market Size by Application (2015-2020)

12 Central & South America

• 12.1 Central & South America Natural Killer (NK) Cell Therapeutics Market Size (2015-2020)
• 12.2 Natural Killer (NK) Cell Therapeutics Key Players in Central & South America (2019-2020)
• 12.3 Central & South America Natural Killer (NK) Cell Therapeutics Market Size by Type (2015-2020)
• 12.4 Central & South America Natural Killer (NK) Cell Therapeutics Market Size by Application (2015-2020)

13 Key Players Profiles

• 13.1 Chipscreen Biosciences (China)
  • 13.1.1 Chipscreen Biosciences (China) Company Details
  • 13.1.2 Chipscreen Biosciences (China) Business Overview
  • 13.1.3 Chipscreen Biosciences (China) Natural Killer (NK) Cell Therapeutics Introduction
  • 13.1.4 Chipscreen Biosciences (China) Revenue in Natural Killer (NK) Cell Therapeutics Business (2015-2020))
  • 13.1.5 Chipscreen Biosciences (China) Recent Development
• 13.2 Affimed NV (Netherlands)
  • 13.2.1 Affimed NV (Netherlands) Company Details
  • 13.2.2 Affimed NV (Netherlands) Business Overview
  • 13.2.3 Affimed NV (Netherlands) Natural Killer (NK) Cell Therapeutics Introduction
  • 13.2.4 Affimed NV (Netherlands) Revenue in Natural Killer (NK) Cell Therapeutics Business (2015-2020)
  • 13.2.5 Affimed NV (Netherlands) Recent Development
• 13.3 Altor BioScience Corporation (USA)
  • 13.3.1 Altor BioScience Corporation (USA) Company Details
  • 13.3.2 Altor BioScience Corporation (USA) Business Overview
  • 13.3.3 Altor BioScience Corporation (USA) Natural Killer (NK) Cell Therapeutics Introduction
  • 13.3.4 Altor BioScience Corporation (USA) Revenue in Natural Killer (NK) Cell Therapeutics Business (2015-2020)
  • 13.3.5 Altor BioScience Corporation (USA) Recent Development
• 13.4 Innate Pharma SA (France)
  • 13.4.1 Innate Pharma SA (France) Company Details
  • 13.4.2 Innate Pharma SA (France) Business Overview
  • 13.4.3 Innate Pharma SA (France) Natural Killer (NK) Cell Therapeutics Introduction
  • 13.4.4 Innate Pharma SA (France) Revenue in Natural Killer (NK) Cell Therapeutics Business (2015-2020)
  • 13.4.5 Innate Pharma SA (France) Recent Development
• 13.5 Takeda Pharmaceutical (Japan)
  • 13.5.1 Takeda Pharmaceutical (Japan) Company Details
  • 13.5.2 Takeda Pharmaceutical (Japan) Business Overview
  • 13.5.3 Takeda Pharmaceutical (Japan) Natural Killer (NK) Cell Therapeutics Introduction
  • 13.5.4 Takeda Pharmaceutical (Japan) Revenue in Natural Killer (NK) Cell Therapeutics Business (2015-2020)
  • 13.5.5 Takeda Pharmaceutical (Japan) Recent Development
• 13.6 Sorrento Therapeutics Inc. (USA)
  • 13.6.1 Sorrento Therapeutics Inc. (USA) Company Details
  • 13.6.2 Sorrento Therapeutics Inc. (USA) Business Overview
  • 13.6.3 Sorrento Therapeutics Inc. (USA) Natural Killer (NK) Cell Therapeutics Introduction
  • 13.6.4 Sorrento Therapeutics Inc. (USA) Revenue in Natural Killer (NK) Cell Therapeutics Business (2015-2020)
  • 13.6.5 Sorrento Therapeutics Inc. (USA) Recent Development
• 13.7 NantKwest Inc. (USA)
  • 13.7.1 NantKwest Inc. (USA) Company Details
  • 13.7.2 NantKwest Inc. (USA) Business Overview
  • 13.7.3 NantKwest Inc. (USA) Natural Killer (NK) Cell Therapeutics Introduction
  • 13.7.4 NantKwest Inc. (USA) Revenue in Natural Killer (NK) Cell Therapeutics Business (2015-2020)
  • 13.7.5 NantKwest Inc. (USA) Recent Development
• 13.8 Bristol-Myers Squibb (USA)
  • 13.8.1 Bristol-Myers Squibb (USA) Company Details
  • 13.8.2 Bristol-Myers Squibb (USA) Business Overview
  • 13.8.3 Bristol-Myers Squibb (USA) Natural Killer (NK) Cell Therapeutics Introduction
  • 13.8.4 Bristol-Myers Squibb (USA) Revenue in Natural Killer (NK) Cell Therapeutics Business (2015-2020)
  • 13.8.5 Bristol-Myers Squibb (USA) Recent Development
• 13.9 NKT Therapeutics (USA)
  • 13.9.1 NKT Therapeutics (USA) Company Details
  • 13.9.2 NKT Therapeutics (USA) Business Overview
  • 13.9.3 NKT Therapeutics (USA) Natural Killer (NK) Cell Therapeutics Introduction
  • 13.9.4 NKT Therapeutics (USA) Revenue in Natural Killer (NK) Cell Therapeutics Business (2015-2020)
  • 13.9.5 NKT Therapeutics (USA) Recent Development

14 Analyst's Viewpoints/Conclusions

15 Appendix

• 15.1 Research Methodology
  • 15.1.1 Methodology/Research Approach
  • 15.1.2 Data Source
• 15.2 Disclaimer